Massberg S, Boros M, Leiderer R, Baranyi L, Okada H, Messmer K
Ludwig-Maximilians University, Institute for Surgical Research, Klinikum Grosshadern, Munich, Germany.
Shock. 1998 Mar;9(3):177-83. doi: 10.1097/00024382-199803000-00004.
The role of endothelin (ET)-1 as a mediator of small intestinal mucosal perfusion failure and tissue damage was investigated in the rat using intravital fluorescence videomicroscopy. The effects of intravenous infusion of ET-1 (3 nmol/kg) on functional capillary density, mucosal thickness, and the degree of mucosal damage were evaluated. Administration of ET-1 caused pronounced mucosal injury with a significant reduction of mucosal thickness compared with vehicle-treated control animals. Concomitantly, villous functional capillary density was markedly reduced 30 and 90 min after the infusion of ET-1. ET(A) receptor blockade by pretreatment with BQ 610 or with the novel ET(A) receptor antagonist ETR-P1/FL peptide prevented ET-1 induced capillary perfusion failure and mucosal damage. In contrast, the ET(B) receptor antagonist IRL 1038 was not effective. These results indicate that, acting via the ET(A) receptor, elevated levels of circulating ET-1 under various pathophysiological conditions, such as septic or hemorrhagic shock, might impair nutritive perfusion of the intestinal mucosa and contribute to tissue injury.
利用活体荧光视频显微镜技术,在大鼠中研究了内皮素(ET)-1作为小肠黏膜灌注衰竭和组织损伤介质的作用。评估了静脉输注ET-1(3 nmol/kg)对功能性毛细血管密度、黏膜厚度和黏膜损伤程度的影响。与给予赋形剂处理的对照动物相比,给予ET-1导致明显的黏膜损伤,黏膜厚度显著降低。同时,在输注ET-1后30分钟和90分钟,绒毛功能性毛细血管密度显著降低。用BQ 610或新型ET(A)受体拮抗剂ETR-P1/FL肽预处理阻断ET(A)受体,可预防ET-1诱导的毛细血管灌注衰竭和黏膜损伤。相比之下,ET(B)受体拮抗剂IRL 1038无效。这些结果表明,在各种病理生理条件下,如脓毒症或失血性休克,循环中ET-1水平升高可能通过ET(A)受体作用,损害肠黏膜的营养灌注并导致组织损伤。